Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization

Hans Peter Hammes, Michael Brownlee, Alfred Jonzcyk, Arne Sutter, Klaus T. Preissner

Research output: Contribution to journalArticlepeer-review

307 Scopus citations

Fingerprint

Dive into the research topics of 'Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds